ESR1 and breast cancer: Since BMP2 inhibits proliferation of ERα+ breast cancer cells, we hypothesized that the increased BMP2-like signaling activity of AB215 may augment AB215’s potency in anti-proliferation of ERα+ breast cancer cells.